John M. Slopis, M. D.
Department of Neuro-Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Neurology, The University of Texas Medical School at Houston, Houston, TX
Medical Director, Neurofibromatosis Program, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Neurology, The University of Texas Medical School at Houston, Houston, TX
Education & Training
Degree-Granting Education
| 1983 | The University of Texas Medical School, Houston, Texas, US, MD |
| 1979 | University of St. Thomas, Houston, Texas, US, BA in Chemistry |
Postgraduate Training
| 1988-1989 | Chief Resident, Neurology, The University of Texas Medical School, Houston, Texas |
| 1986-1989 | Research Fellowship, Pediatric Neurology, The University of Texas Medical School, Houston, Texas |
| 1984-1986 | Clinical Residency, Pediatrics, The University of Texas Medical School, Houston, Texas |
| 1983-1984 | Clinical Internship, Pediatrics, The University of Texas Medical School, Houston, Texas |
Licenses & Certifications
| 1989 | Texas Medical Board License |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 1998 - 2014
Associate Professor, Department of Child & Adolescent Neurology, The University of Texas Medical School at Houston, Houston, TX, 1998 - 2002
Assistant Professor, Department of Child & Adolescent Neurology, The University of Texas Medical School at Houston, Houston, TX, 1989 - 1998
Administrative Appointments/Responsibilities
Medical Director, Neurofibromatosis Program, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - Present
Other Professional Positions
Member, Neurofibromatosis Working Group, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - Present
Member, Brain Tumor Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 1998 - Present
Member, Medical School Animal Welfare Committee, The University of Texas Medical School at Houston, Houston, TX, 1998 - 2001
Member, Student Evaluation and Promotions Committee, The University of Texas Medical School at Houston, Houston, TX, 1996 - 2001
Member, Course Directors Subcommittee, Medical School Curriculum Committee, The University of Texas Medical School at Houston, Houston, TX, 1995 - 2001
Chairman, Pediatric Post Graduate Training Subcommittee, Department of Pediatric Internal Review Committee, The University of Texas Medical School at Houston, Houston, TX, 1994 - Present
Chairman, Pediatric Faculty Development Subcommittee, Department of Pediatrics Retreat, The University of Texas Medical School at Houston, Houston, TX, 1990 - Present
Member, Medical Clerkship Committee, The University of Texas Medical School at Houston, Houston, TX, 1990 - 2000
Active Teaching Medical Staff, Memorial Hermann Hospital, Houston, TX, 1989 - 2013
Medical Staff, Shriners Hospital for Children, Houston, TX, 1989 - 2011
Extramural Institutional Committee Activities
Member, The Neurologic Death Task Force of the ICU Best Practice Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present
Editorial Activities
Member, Editorial Board, Journal of Child Neurology, 2011 - Present
Honors & Awards
| 2016 | Honorary Chairman at Dining Out in Dallas, Texas Neurofibromatosis Foundation |
| 2010 - 2024 | America's Top Pediatrician, Consumers' Research Council of America |
| 2010 | 30th Anniversary Award, Texas Neurofibromatosis Foundation |
| 2007 - 2024 | Listed among 100 Best Doctors in America |
| 2007 | "Top Doc" Achievement Award in Clinical Care and Research in Neurofibromatosis, Texas Neurofibromatosis Foundation |
| 1989 | Annual Dean's Excellence Award for Faculty Teaching, The University of Texas Medical School at Houston |
| 1987 | Residency Teaching Award, Department of Neurology, The University of Texas Medical School at Houston |
| 1985 - 1986 | Residency Teaching Award, Department of Pediatrics, The University of Texas Medical School at Houston |
| 1983 | Basic Science Research Award, The University of Texas Medical School at Houston |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2014. The Added Value of a 3-D, Heavily T2-Weighted Sequence for MR Imaging of the Brachial Plexus. Conference. The Added Value of a 3-D, Heavily T2-Weighted Sequence for MR Imaging of the Brachial Plexus. Houston, TX, US.
- 2014. Reducing Multiple Rescheduling of Patient Appointments. Conference. Reducing Multiple Rescheduling of Patient Appointments. Houston, TX, US.
- 2010. Neurofibromatosis Type 1 Update 2010. Conference. Neurofibromatosis Type 1 Update 2010. Houston, TX, US.
- 2008. Treatment Trials in Neurofibromatosis. Conference. Treatment Trials in Neurofibromatosis. Houston, TX, US.
- 2007. Research Update. Conference. Research Update. Houston, TX, US.
- 2007. Learning Disabilities and Intervention in Neurofibromatosis. Conference. Learning Disabilities and Intervention in Neurofibromatosis. Houston, TX, US.
- 2004. Neurofibromatosis: Neurologic Manifestations. Conference. Neurofibromatosis: Neurologic Manifestations. Houston, TX, US.
Regional Presentations
- 2009. Diagnosis and Implications for Outcome in NF I. Conference. Diagnosis and Implications for Outcome in NF I. San Antonio, TX, US.
- 2009. Learning Disabilities in NF1. Conference. Learning Disabilities in NF1. San Antonio, TX, US.
- 2009. New Orthopedic Developments in Neurofibromatosis. Conference. New Orthopedic Developments in Neurofibromatosis. San Antonio, TX, US.
- 2008. Clinical Overview of Neurofibromatosis Type 1. Conference. Clinical Overview of Neurofibromatosis Type 1. Little Rock, AR, US.
- 2005. Neurofibromatosis: Neurologic Manifestations. Conference. Neurofibromatosis: Neurologic Manifestations. Dallas, TX, US.
- 2005. Clinical Overview of Neurofibromatosis. Conference. Clinical Overview of Neurofibromatosis, TX, US.
National Presentations
- 2018. Primary Leptomeningeal Medulloblastoma: rare presentation. Conference. Poster Session: 2018 AAN Conference, US.
- 2015. Anesthetic management of a pediatric patient with amyotrophic lateral sclerosis (ALS) for spinal cord injection of stem cells. Conference. Poster Session: 2015 Conference. San Diego, CA, US.
- 2015. Unraveling the sensitivity of malignant peripheral nerve sheath tumor (MPNST) to poly (ADP) ribose polymerase inhibition. Conference. Poster Session: 2015 NF Conference. Monterey, CA, US.
- 2015. Autologous stem cell transplantation to spinal cord for juvenile amyotrophic lateral sclerosis. Conference. Poster Session: 2015 Conference. San Diego, CA, US.
- 2014. Case Study: A patient with Neurofibromatosis Type 1, Accessory renal artery and Pheochromotocytoma. Conference. Poster Session: 2014 NF Conference. Washington, DC, US.
- 2014. The frequency of LZTR1 mutations in a schwannomatosis Cohort. Conference. Poster Session: 2014 NF Conference. Washington, DC, US.
- 2011. Diffuse leptomeningeal relapse following gross total resection in a spinal cord pilocytic astrocytoma with oligodendroglial features and 1p19q deletion. Conference. Poster Session: Medical & Neuro-Oncology, 16th Annual Meeting. Orange County, CA, US.
- 2010. A Clinician's Perspective on Neurofibromatosis. Conference. 44th Annual Meeting. Houston, TX, US.
- 2010. Master's Series Tumor Board: Neurofibromatosis. Conference. 44th Annual Meeting. Houston, TX, US.
- 2009. Canine Models of Brain Tumors. Conference. The Choroid Plexus Tumor Research Conference. Houston, TX, US.
- 2005. Congenital Anomalies of Frontal Cortex in NF-1. Conference. Neurofibromatosis Meeting. Aspen, CO, US.
- 2005. Neurocutaneous Syndromes. Conference. Child Neurology Update. Houston, TX, US.
International Presentations
- 2011. Looking through the patient's eyes. Conference. Poster Session: Brain Tumors-Molecular Genetics/Translational Research Side Effects, 43rd Congress. Auckland, NZ.
- 2011. Treatment of patients with advanced neurofibromatosis type 2 (NF2) with novel molecularly targeted therapies. Conference. CNS Tumors Poster Session, 2011 Annual Meeting. Chicago, US.
Formal Peers
- 2006. Visiting Professor. Visiting. Memphis, TN, US.
- 2003. Visiting Professor. Visiting. Seattle, WA, US.
Grant & Contract Support
| Date: | 2011 - 2014 |
| Title: | Topical Rapamycin Therapy to Relieve Cutaneous Manifestations of Tuberous Sclerosis Complex |
| Funding Source: | DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP) |
| Role: | Co-I |
| ID: | TS100017 |
| Date: | 2009 - 2011 |
| Title: | Signaling Pathways Involving SRC and the SRC Inhibitor Dasatinib in Neurofibromatosis Type 2 |
| Funding Source: | Terrill Foundation |
| Role: | Co-PI |
| Date: | 2009 - 2010 |
| Title: | Treatment Trial of Cutaneous Lesions of Tuberous Sclerosis and Neurofibromatosis Type 1 |
| Funding Source: | Chenier Corporation, Race Across America (RAAM) |
| Role: | Co-PI |
| Date: | 2009 - 2011 |
| Title: | Genotype-Phenotype Correlations Predicting Malignant Tumors in NF type 1 (This project remains "on hold" due to administrative changes in the research group) |
| Funding Source: | Texas Neurofibromatosis Foundation (TNFF) |
| Role: | Co-PI |
| Date: | 2007 - 2010 |
| Title: | Infrastructure Development for Clinical Trials in Neurofibromatosis |
| Funding Source: | Texas Neurofibromatosis Foundation (TNFF) |
| Role: | Co-PI |
| Date: | 2003 - 2005 |
| Title: | Intralumbar Injection for Cancer Therapy using I-131 Nal |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | CA097729-01A2 |
| Date: | 1999 - 2004 |
| Title: | Neurobiology of cognitive impairment in children with NF |
| Funding Source: | National Institutes of Health |
| Role: | Co-I |
| ID: | R01 NS 31950-05 |
| Date: | 1999 - 2002 |
| Title: | Social and Emotional Functioning of Children with NF-1 and Their Families: A Case Controlled Study |
| Funding Source: | Department of Defense |
| Role: | Co-I |
| Date: | 1996 - 2001 |
| Title: | Microdialysis of NAA and NAAG in Focal Epileptogenesis |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | NS 01779 NST |
| Date: | 1995 - 1999 |
| Title: | Neurobiology of Cognitive impairment in Children with NF |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | NS31950 |
| Date: | 1990 - 1992 |
| Title: | In-Vivo Proton Magnetic Resonance Spectroscopy studies of Anticonvulsant-Induced Changes in Animal Brain |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 1990 - 1991 |
| Title: | Magnetic Resonance Spectroscopy Disease and Developing Muscle |
| Funding Source: | Muscular Dystrophy Association |
| Role: | Co-I |
| Date: | 1989 - 1992 |
| Title: | In-Vivo Proton Magnetic Resonance Spectroscopic Studies of Muscular Disease |
| Funding Source: | Shriner's Hospital for Crippled Children |
| Role: | PI |
| Date: | 1988 - 1992 |
| Title: | Neuropsychologic Assessment of Children with Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | CA33097-07A1 |
| Title: | Oral Afinitor to Treat Cutaneous Neurofibromata in NF 1-Investigator Initiated Trial; Approved through IRB, enrolling subjects-January 2015 |
| Funding Source: | Novartis |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Piha-Paul, SA, Tseng, C, Thompson, E, Stafford, RJ, Le, H, Kang, L, Fu, S, Tsimberidou, AM, Blumenschein, GR, Rodon Ahnert, J, Slopis, JM, Hong, DS, Naing, A, Meric-Bernstam, F, Ng, CS, Westin, SN, Sood, AK. Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies. Oncologist 31(3), 2026. e-Pub 2026. PMID: 41389341.
- Alqahtani, S, Bitar, SD, Mireles, ME, Corrales-Medina, FF, Herzog, CE, Slopis, JM, Daw Bitar, N. Ifosfamide-Induced Encephalopathy in Children and Young Adults. Cancers 17(13), 2025. e-Pub 2025. PMID: 40647490.
- Dasgupta, P, McCutcheon, IE, Slopis, JM. A Massive Thoracic Meningocele in a Patient with NF1. Canadian Journal of Neurological Sciences 52(2):311, 2025. e-Pub 2025. PMID: 39358987.
- Benkli B, Vu PD, Abd-Elsayed A, Slopis JM, Geng Y, Chung M. Chronic Pain in Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis: A Review on Epidemiology, Pathophysiology, Symptomatology and Treatment. Pain Physician 28(2):105-115, 2025. e-Pub 2025. PMID: 40408317.
- He J, Connors J, Meador A, Xu S, Meador H, Jiang H, Fueyo J, Gomez-Manzano C, Friedman GK, Zaky W, Sadighi Z, Slopis JM, Ahmad AH. Immunotherapy-related neurotoxicity in the central nervous system of children with cancer. NeuroOncol 27(3):625-643, 2025. e-Pub 2025. PMID: 39535217.
- Tomczak, K, Patel, MS, Bhalla, A, Peterson, CB, Landers, S, Callahan, SC, Zhang, D, Wong, J, Landry, JP, Lazar, A, Livingston, JA, Guadagnolo, BA, Lyu, H, Lillemoe, HA, Roland, CL, Keung, EZ, Scally, CP, Hunt, KK, McCutcheon, IE, Slopis, JM, Gu, J, Scheet, PA, Wang, L, Rai, K, Torres, KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Molecular Carcinogenesis 64(1):44-56, 2025. e-Pub 2025. PMID: 39600120.
- Tomczak K, Patel MS, Bhalla AD, Peterson CB, Landers SM, Callahan S, Zhang D, Wong J, Landry JP, Lazar AJ, Livingston J, Guadagnolo B, Lyu HG, Lillemoe H, Roland CL, Keung EZ, Scally CP, Hunt KK, McCutcheon IE, Slopis JM, Gu J, Scheet P, Wang L, Rai K, Torres KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Mol Carcinog 64(1):44-56, 2025. e-Pub 2025. PMID: 39600120.
- Lam K, Kamiya-Matsuoka C, Slopis JM, McCutcheon IE, Majd NK. Therapeutic Strategies for Gliomas Associated With Cancer Predisposition Syndromes. JCI Precis Oncol 8, 2024. e-Pub 2024. PMID: 38394467.
- Sarkar, S, Throckmorton, WR, Bingham, R, Msaouel, P, Genovese, G, Slopis, JM, Rao, P, Sadighi, ZS, Herzog, CE. Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2. Current Oncology 30(3):3355-3365, 2023. e-Pub 2023. PMID: 36975468.
- Bhalla, A, Landers, S, Singh, A, Landry, JP, Yeagley, M, Myerson, GS, Delgado-Baez, CB, Dunnand, S, Nguyen, T, Ma, X, Bolshakov, S, Menegaz, BA, Lamhamedi-Cherradi, SE, Mao, X, Song, X, Lazar, A, McCutcheon, IE, Slopis, JM, Ludwig, JA, Chelouche Lev, D, Rai, K, Torres, KE. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor. Laboratory Investigation 102(6):658-666, 2022. e-Pub 2022. PMID: 35228656.
- Kochat, V, Raman, AT, Landers, S, Tang, M, Schulz, J, Terranova, C, Landry, JP, Bhalla, A, Beird, H, Wu, C, Jiang, Y, Mao, X, Segura Lazcano, R, Gite, S, Ingram, D, Yi, M, Zhang, J, Keung, EZ, Scally, CP, Roland, CL, Hunt, KK, Feig, BW, Futreal, A, Hwu, P, Wang, W, Lazar, A, Slopis, JM, Wilson, H, Wiener, DJ, McCutcheon, IE, Wustefeld-Janssens, B, Rai, K, Torres, KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta neuropathologica 142(3):565-590, 2021. e-Pub 2021. PMID: 34283254.
- North, RY, Snyder, R, Slopis, JM, McCutcheon, IE. Surgical treatment of common peroneal neuropathy in schwannomatosis. Journal of Neurosurgery: Case Lessons 1(26), 2021. e-Pub 2021. PMID: 35854908.
- Cabrera TB, Wang W, Yedururi S, Slopis JM, Steiner RE, Rytting ME, Cuglievan B. Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review. J Pediatr Hematol Oncol 43(4):e535-e538, 2021. e-Pub 2021. PMID: 32366782.
- Landry, JP, Schertz, KL, Chiang, YJ, Bhalla, A, Yi, M, Keung, EZ, Scally, CP, Feig, BW, Hunt, KK, Roland, CL, Guadagnolo, BA, Bishop, AJ, Lazar, A, Slopis, JM, McCutcheon, IE, Torres, KE. Comparison of Cancer Prevalence in Patients with Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population from 1985 to 2020. JAMA Network Open 4(3), 2021. e-Pub 2021. PMID: 33734413.
- Brown, BD, Tambaro, FP, Kohorst, MA, Chi, TL, Mahadeo, KM, Tewari, P, Petropoulos, D, Slopis, JM, Sadighi, ZS, Khazal, SJ. Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy. Frontiers in Oncology 11, 2021. e-Pub 2021. PMID: 33763368.
- Koczkowska M, Callens T, Chen Y, Gomes A, Hicks AD, Sharp A, Johns E, Uhas KA, Armstrong L, Bosanko KA, Babovic-Vuksanovic D, Baker L, Basel DG, Bengala M, Bennett JT, Chambers C, Clarkson LK, Clementi M, Cortés FM, Cunningham M, D'Agostino MD, Delatycki MB, Digilio MC, Dosa L, Esposito S, Fox S, Freckmann ML, Fauth C, Giugliano T, Giustini S, Goetsch A, Goldberg Y, Greenwood RS, Griffis C, Gripp KW, Gupta P, Haan E, Hachen RK, Haygarth TL, Hernández-Chico C, Hodge K, Hopkin RJ, Hudgins L, Janssens S, Keller K, Kelly-Mancuso G, Kochhar A, Korf BR, Lewis AM, Liebelt J, Lichty A, Listernick RH, Lyons MJ, Maystadt I, Martinez Ojeda M, McDougall C, McGregor LK, Melis D, Mendelsohn N, Nowaczyk MJM, Ortenberg J, Panzer K, Pappas JG, Pierpont ME, Piluso G, Pinna V, Pivnick EK, Pond DA, Powell CM, Rogers C, Ruhrman Shahar N, Rutledge SL, Saletti V, Sandaradura SA, Santoro C, Schatz UA, Schreiber A, Scott DA, Sellars EA, Sheffer R, Siqveland E, Slopis JM, Smith R, Spalice A, Stockton DW, Streff H, Theos A, Tomlinson GE, Tran G, Trapane PL, Trevisson E, Ullrich NJ, Van den Ende J, Schrier Vergano SA, Wallace SE, Wangler MF, Weaver DD, Yohay KH, Zackai E, Zonana J, Zurcher V, Claes KBM, Eoli M, Martin Y, Wimmer K, De Luca A, Legius E, Messiaen LM. Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1. Hum Mutat 41(1):299-315, 2020. e-Pub 2020. PMID: 31595648.
- Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ. Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nature Reviews, Clinical Oncology 16(1):45-63, 2019. e-Pub 2019. PMID: 30082906.
- D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A. The molecular landscape of glioma in patients with Neurofibromatosis 1. Nature Medicine 25(1):176-187, 2019. e-Pub 2019. PMID: 30531922.
- Young ED, Ingram D, Metcalf-Doetsch W, Khan D, Al Sannaa G, Le Loarer F, Lazar AJF, Slopis J, Torres KE, Lev D, Pollock RE, McCutcheon IE. Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers. Journal of Neurosurgery 129(3):805-814, 2018. e-Pub 2018. PMID: 28885122.
- Koenig MK, Bell CS, Hebert AA, , Roberson J, Samuels JA, Slopis JM, Tate P, Northrup H. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial. JAMA Dermatology 154(7):773-780, 2018. e-Pub 2018. PMID: 29800048.
- Jittapiromsak N, Hou P, Liu HL, Sun J, Slopis JM, Chi TL. Prognostic Role of Conventional and Dynamic Contrast-Enhanced MRI in Optic Pathway Glioma in Journal of Neuroimaging. Journal of Neuroimaging 27(6):594-601, 2017. e-Pub 2017. PMID: 28524459.
- Rosnau K, Hashmi SS, Northrup H, Slopis J, Noblin S, Ashfaq M. Knowledge and Self-Esteem of Individuals with Neurofibromatosis Type 1 (NF1). J Genet Couns 26(3):620-627, 2017. e-Pub 2016. PMID: 27815662.
- Ostrow KL, Bergner AL, Blakeley J, Evans DG, Ferner R, Friedman JM, Harris GJ, Jordan JT, Korf B, Langmead S, Leschziner G, Mautner V, Merker VL, Papi L, Plotkin SR, Slopis JM, Smith MJ, Stemmer-Rachamimov A, Yohay K, Belzberg AJ. Creation of an international registry to support discovery in schwannomatosis. Am J Med Genet A 173(2):407-413, 2017. e-Pub 2016. PMID: 27759912.
- Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg 126(1):1-11, 2017. e-Pub 2016. PMID: 27035165.
- Ghali MGZ, Srinivasan VM, Jea A, Slopis JM, McCutcheon IE. Neurofibromas of the Phrenic Nerve: A Case Report and Review of the Literature. World Neurosurg 88:237-242, 2016. e-Pub 2016. PMID: 26746336.
- Kivlin CM, Watson KL, Al Sannaa GA, Belousov R, Ingram DR, Huang KL, May CD, Bolshakov S, Landers SM, Kalam AA, Slopis JM, McCutcheon IE, Pollock RE, Lev D, Lazar AJ, Torres KE. Poly (ADP) Ribose Polymerase Inhibition: A Potential Treatment of Malignant Peripheral Nerve Sheath Tumor. Cancer Biol Ther 17(2):0, 2016. e-Pub 2016. PMID: 26650448.
- Wilson, A, Slopis, JM, Andrassy, RJ, Dhingra, S, Austin, M. Surgical management of an appendiceal neurofibroma in a neurofibromatosis-1 patient. Journal of Pediatric Surgery Case Reports 3(11):492-495, 2015. e-Pub 2015.
- Wilson A, Slopis JM, Andrassy R, Dhingra S, Austin M. Surgical management of an appendiceal neurofibroma in a neurofibromatosis-1 patient: A case report. Journal of Pediatric Surgery Case Reports 3(11), 2015.
- Subbiah V, Bupathi M, Kato S, Livingston A, Slopis J, Anderson PM, Hong DS. Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients. Oncoscience 2(7):646-58, 2015. e-Pub 2015. PMID: 26328274.
- Debnam JM, Mahfouz YM, Ketonen L, Slopis JM, McCutcheon IE, Guha-Thakurta N. Multidetector CT with 3-dimensional Volume Rendering in the Evaluation of the Spine in Patients with Neurofibromatosis Type 1: A Retrospective Review of 73 Patients. Scoliosis 9:15:1-10. e-Pub 2014. PMID: 25852768.
- Khiewvan B, Macapinlac HA, Lev D, McCutcheon IE, Slopis JM, Al Sannaa G, Wei W, Chuang HH. The value of ¹ F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging 41(9):1756-66, 2014. e-Pub 2014. PMID: 24699907.
- Theeler BJ, Ellezam B, Yust-Katz S, Slopis JM, Loghin ME, de Groot JF. Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab. J Neurol 261(8):1559-1564, 2014. e-Pub 2014. PMID: 24859329.
- Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46(2):182-7, 2014. e-Pub 2014. PMID: 24362817.
- Debnam JM, Mahfouz YM, Ketonen L, Slopis JM, McCutcheon IE, Guha-Thakurta N. Multidetector CT with 3-dimensional volume rendering in the evaluation of the spine in patients with Neurofibromatosis type 1: a retrospective review in 73 patients. Scoliosis 9(1):15, 2014. e-Pub 2014. PMID: 25852768.
- Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM. Germiline loss-of-function mutations in LZTR1 predispose to an inherited idsorder of multiple schwannomas. Nature Genetics 46:182-187, 2013. e-Pub 2013.
- Angelo LS, Maxwell DS, Wu JY, Sun D, Hawke DH, McCutcheon IE, Slopis JM, Peng Z, Bornmann WG, Kurzrock R. Binding partners for curcumin in human schwannoma cells: biologic implications. Bioorg Med Chem 21(4):932-9, 2013. e-Pub 2013. PMID: 23294827.
- Zipp L, Schwartz KM, Hewer E, Yu Y, Stippich C, Slopis JM. Magnetic resonance imaging and computed tomography findings in pediatric giant cell glioblastoma. Clin Neuroradiol 22(4):359-63, 2012. e-Pub 2012. PMID: 22286149.
- Sadighi Z, Slopis JM. Pilocytic Astrocytoma: a disease with evolving molecular heterogeneity. JCN, 2012. e-Pub 2012.
- Koenig MK, Hebert AA, Roberson J, Samuels J, Slopis J, Woerner A, Northrup H. Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberouos sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin. Drugs RD 12(3):121-126, 2012. e-Pub 2012.
- Subbiah V, Slopis J, Ketonen L, Hamilton J. Treatment of patients with advanced neurofibromatosis type 2 (NF2) with novel molecularly targeted therapies: from bench to bedside. J Clin Oncol 30(5):e64-e68, 2012. e-Pub 2012.
- Subbiah V, Slopis J, Hong DS, Ketonen LM, Hamilton J, McCutcheon IE, Kurzrock R. Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside. J Clin Oncol 30(5):e64-8, 2012. e-Pub 2012. PMID: 22203760.
- Koenig, MK, Hebert, AA, Roberson, J, Samuels, J, Slopis, JM, Woerner, A, Northrup, H. Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex. Drugs in R and D 12(3):121-126, 2012. e-Pub 2012. PMID: 22934754.
- Angelo LS, Wu JY, Meng F, Sun M, Kopetz S, McCutcheon IE, Slopis JM, Kurzrock R. Combining Curcumin (Diferuloylmethane) and Heat Shock Protein Inhibition for Neurofibromatosis 2 Treatment: Analysis of Response and Resistance Pathways. Mol Cancer Ther 10(11):2094-2103, 2011. e-Pub 2011. PMID: 21903608.
- Pearlman M, Frye R, Butler I, Papanicolaou AC, Castillo E, Slopis J. Patterns of electromagnetic activity recorded from neoplastic tissue. J Neurooncol 105(2):445-449, 2011. e-Pub 2011. PMID: 21573889.
- Lopez G, Torres K, Liu J, Hernandez B, Young E, Belousov R, Bolshakov S, Lazar AJ, Slopis JM, McCutcheon IE, McConkey D, Lev D. Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res 71(1):185-96, 2011. e-Pub 2011. PMID: 21084276.
- Rokes C, Ketonen LM, Fuller GN, Weinberg J, Slopis JM, Wolff JE. Imaging and spectroscopic findings in meningioangiomatosis. Pediatr Blood Cancer 53(4):672-4, 2009. e-Pub 2009. PMID: 19544396.
- Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 249(6):1014-22, 2009. e-Pub 2009. PMID: 19474676.
- Zou CY, Smith KD, Zhu QS, Liu J, McCutcheon IE, Slopis JM, Meric-Bernstam F, Peng Z, Bornmann WG, Mills GB, Lazar AJ, Pollock RE, Lev D. Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther 8(5):1157-68, 2009. e-Pub 2009. PMID: 19417153.
- Koenig MK, Sitton CW, Wang M, Slopis JM. Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications. J Child Neurol 23(11):1347-52, 2008. e-Pub 2008. PMID: 18984849.
- Billingsley RL, Jackson EF, Slopis JM, Swank PR, Mahankali S, Moore BD. Functional MRI of visual-spatial processing in neurofibromatosis, type I. Neuropsychologia 42(3):395-404, 2004. e-Pub 2004. PMID: 14670578.
- Billingsley RL, Jackson EF, Slopis JM, Swank PR, Mahankali S, Moore BD. Functional magnetic resonance imaging of phonologic processing in neurofibromatosis 1. J Child Neurol 18(11):731-40, 2003. e-Pub 2003. PMID: 14696899.
- Schrimsher GW, Billingsley RL, Slopis JM, Moore BD. Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genet A 120A(3):326-30, 2003. e-Pub 2003. PMID: 12838550.
- Billingsley RL, Slopis JM, Swank PR, Jackson EF, Moore BD. Cortical morphology associated with language function in neurofibromatosis, type I. Brain Lang 85(1):125-39, 2003. e-Pub 2003. PMID: 12681352.
- Chan KW, Mullen CA, Worth LL, Choroszy M, Koontz S, Tran H, Slopis J. Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplant 29(12):963-5, 2002. e-Pub 2002. PMID: 12098063.
- Billingsley RL, Schrimsher GW, Jackson EF, Slopis JM, Moore BD. Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1. Arch Neurol 59(4):616-22, 2002. e-Pub 2002. PMID: 11939897.
- Billingsley RL, Lang FF, Slopis JM, Schrimsher GW, Ater JL, Moore BD. Visual-spatial neglect in a child following sub-cortical tumor resection. Dev Med Child Neurol 44(3):191-9, 2002. e-Pub 2002. PMID: 12008674.
- Neville HL, Seymour-Dempsey K, Slopis J, Gill BS, Moore BD, Lally KP, Andrassy RJ. The role of surgery in children with neurofibromatosis. J Pediatr Surg 36(1):25-29, 2001. e-Pub 2001. PMID: 11150433.
- Vassilopoulou-Sellin R, Klein MJ, Slopis JK. Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions. Pediatr Neurol 22(5):355-8, 2000. e-Pub 2000. PMID: 10913726.
- Moore BD, Slopis JM, Jackson EF, De Winter AE, Leeds NE. Brain volume in children with neurofibromatosis: relation to neuropsychological status. Neurology 54(4):25-9, 2000. e-Pub 2000. PMID: 10690986.
- Kayl AE, Moore BD, Slopis JM, Jackson EF, Leeds NE. Quantitative morphology of the callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 15(2):90-96, 2000. e-Pub 2000. PMID: 10695893.
- Worth LL, Slopis JM, Herzog CE. Congenital hepatoblastoma and schizencephaly in an infant with Beckwith-Wiedemann syndrome. Med Pediatr Oncol 33(6):591-3, 1999. e-Pub 1999. PMID: 10573588.
- De Winter AE, Moore BD, Slopis JM, Ater JL, Copeland DR. Brain tumors in children with neurofibromatosis: additional neuropsychological morbidity?. Neuro Oncol 1(4):275-81, 1999. e-Pub 1999. PMID: 11550319.
- Slopis, JM. Clinical overview and application of advanced neuroimaging techniques in management of neurofibromatosis. International Journal of Pediatric Hematology/Oncology 5(1):56-57, 1998. e-Pub 1998.
- Kramer LA, Crino JP, Slopis J, Hankins L, Yeakley J. Capillary Hemangioma of the Neck: Prenatal MR Findings. AJNR Am J Neuroradiol 18(8):1432-1434, 1997. e-Pub 1997. PMID: 9296183.
- Ater JL, Moore BD, Francis DJ, Castillo R, Slopis J, Copeland DR. Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: utilization of a neurological severity score. J Child Neurol 11(6):462-9, 1996. e-Pub 1996. PMID: 9120225.
- Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46(6):1660-8, 1996. e-Pub 1996. PMID: 8649566.
- Lin SN, Slopis JM, Butler IJ, Caprioli RM. In Vivo Microdialysis and Gas Chromatography/Mass Spectrometry for Studies in Release of N-Acetylaspartylglumate and N-Acetylaspartate in Rat Brain Hypothalamus. J Neurosci Methods 62(1-2):199-205, 1995. e-Pub 1995. PMID: 8750104.
- Dimachkie MM, Austin SG, Slopis JM, Vriesendorp FJ. Critical Illness polyneuropathy in adolescence. J Child Neurol 9(5):193, 1995. e-Pub 1995. PMID: 7499764.
- Mancias P, Slopis JM, Yeakley JW, Vriesendorp FJ. Combined brachial plexopathy and root avulsion in a neonate. Muscle Nerve 17(10):1237-1238, 1994. e-Pub 1994. PMID: 7935545.
- Moore BD, Ater JL, Needle MN, Slopis J, Copeland DR. Neurophysichological profiles of children with neurofibromatosis, brain tumor, or both. J Child Neurol 9(4):368-377, 1994. e-Pub 1994. PMID: 7822726.
- Ramirez M, Wilkins I, Kramer L, Slopis J, Taylor SR. Prenatal diagnosis of unilateral megalencephaly by real-time ultrasonography. Am J Obstet Gynecol 170(5):1384-1385, 1994. e-Pub 1994. PMID: 8178875.
- Slopis JM, Jackson EF, Narayana PA, Papasozomenos SC, Butler IJ. Proton Magnetic resonance imaging and spectroscopic studies of the pathogenesis and treatment of juvenile. J Child Neurol 8(3):242-249, 1993. e-Pub 1993. PMID: 8409266.
- Dominguez R, Aguirre Vila-Coro A, Slopis JM, Bohan TP. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 145(6):688-95, 1991. e-Pub 1991. PMID: 1709777.
- Narayana PA, Slopis JM, Jackson EF, Jankovic J, Butler IJ. Proton magnetic resonance spectroscopic studies of hypertrophied muscle: Effect of botulinum toxin treatment. Invest Radiol 26(1):58-64, 1991. e-Pub 1991. PMID: 2022454.
- Fotedar LK, Slopis JM, Narayana PA, Fenstermacher MJ, Pivarnik J, Butler IJ. Proton magnetic resonance of exercise induced water changes in gastrocnemius muscle. J Appl Physiol 69(5):1695-1701, 1990. e-Pub 1990. PMID: 2177054.
- Narayana PA, Slopis JM, Jackson EF, Hazle JD, Kulkarni MV, Butler IJ. In vivo muscle proton magnetic resonance spectroscopy studies in mitochondrial cytopathy. Magn Reson Imaging 7(2):133-139, 1989. e-Pub 1989. PMID: 2716480.
- Takaue Y, Slopis JM, Anzai T, Robertson R, Jaffe N. Successful treatment of pulmonary and abdominal metastatic osteosarcoma. Med Pediatr Oncol 13(3):126-128, 1985. e-Pub 1985. PMID: 3857430.
- Kendall DA, Duman R, Slopis J, Enna SJ. The influence of ACTH and Yohimbine on antidepressant-induced decline in rat brain neurotransmitter receptor binding and function. J Pharmacol Exp Ther 222(3):566-571, 1982. e-Pub 1982. PMID: 6286924.
- Kitagawa RH, Slopis JM, Tummala S, Lin V, Smitherman S, McCutcheon IE. Surgical treatment of intrinsic tumors of the sciatic nerve. Neurosurgery.
Review Articles
- Benkli, B, Vu, P, Abd-Elsayed, A, Slopis, JM, Geng, Y, Chung, M. Chronic Pain in Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis. Pain physician 28(2):105-115, 2025. e-Pub 2025. PMID: 40408317.
- He, J, Connors, JS, Meador, A, Xu, S, Meador, H, Jiang, H, Fueyo-Margareto, J, Gomez-Manzano, C, Friedman, GK, Zaky, W, Sadighi, ZS, Slopis, JM, Ahmad, AH. Immunotherapy-related neurotoxicity in the central nervous system of children with cancer. Neuro-oncology 27(3):625-643, 2025. e-Pub 2025. PMID: 39535217.
- Lam, K, Kamiya Matsuoka, C, Slopis, JM, McCutcheon, IE, Majd, NK. Therapeutic Strategies for Gliomas Associated with Cancer Predisposition Syndromes. JCO Precision Oncology 8, 2024. e-Pub 2024. PMID: 38394467.
- Sadighi, ZS, Slopis, JM. Pilocytic astrocytoma. Unknown Journal 28(5):625-632, 2013. e-Pub 2013. PMID: 23439714.
- Kramer LA, Villar-Cordova C, Wheless JW, Slopis J, Yeakley J. Magnetic resonance angiography of primary varicella vasculitis: report of two cases. J Magn Reson Imaging 9(3):491-6, 1999. e-Pub 1999. PMID: 10194723.
Professional Educational Materials
- Slopis JM, Terrill RC. A Guide for Patients and Families Living with Neurofibromatosis. Medical Editors, 2006.
Abstracts
- Slopis JM, Arevalo O, Bell CS, Hebert AA, Northrup H, Riascos RF, Samuels JA, Smith KC, Tate P, Koenig MK. Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial. Drugs in R&D 18(4):295-302, 2018. e-Pub 2018. PMID: 30284154.
- Kochat V, , Raman A, Landers SM, Terranova C, Wu CC, Mao X, Ingram D, Mulder ZA, Yeagley MA, Bierd H, Bhalla A, McCutcheon I, Slopis J, Zhang J, , Futreal A, Wang WL, Lazar A, Rai K, and Torres KE, . CHROMATIN STATE TRANSITIONS ASSOCIATED WITH PRC2 FUNCTIONAL LOSS DRIVE A DE-DIFFERENTIATED PHENOTYPE IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS. Connective Tissue Oncology Society, 2018. e-Pub 2018.
- Joy S, Miller M, Slopis JM. Case Study: A patient with Neurofibromatosis Type 1, Accessory renal artery and Pheochromotocytoma, 2014. e-Pub 2014.
- Young ED, Ingram D, Metcalf-Doetsch W, Khan D, LeLoarer F, Lazar A JF, McCutcheon IE, Slopis JM, Torres KE, Pollock RE, Lev D. A Clinicopathologic Portrait of Sporadic Peripheral Schwannomas, 2013. e-Pub 2013.
- Kivlin CM, Ma XY, Ingram D, Al Sannaa GA, May C, Garnett J, Bolshakov S, McCutcheon I, Slopis JM, Lev D, Lazar AJ, Torres KE. An Innovative Combination Therapy for the Treatment of Malignant Peripheral Nerve Sheath Tumor (MPNST), 2013. e-Pub 2013.
- Ma X, May C, Kivlin CM, Uzunparmak B, Han L, Zhou F, Ingram D, Al Sannaa GA, Garnett J, Bolshakov S, McCutcheon I, Slopis JM, Lev D, Lazar AJ, Torres KE. Inhibition of Axl Enhance the Sensitivity of Malignant Peripheral Nerve Sheath Tumores to Mek Inhibition, 2013. e-Pub 2013.
- Kivlin CM, Ma XY, Ingram D, Al Sannaa GA, Feng Y, May C, Bolshakov S, McCutcheon I, Slopis JM, Lev D, Lazar AJ, Torres KE. BMN 673, A Novel Potent Parp Inhibitor for the Treatment of Malignant Peripheral Nerve Sheath Tumore (MPNST). Presented at the CTOS 2013 Annual Meeting, October 30-November 2, 2013, New York, 2013. e-Pub 2013.
- Al Sannaa G, Ingram D, Unlu O, Slopis J, McCutcheon I, Torres K, Lazar A. The Impact of Neurofibromatosis Type 1 Status on Malignant Peripheral Nerve Sheath Tumors Patient Outcom. Presented at the CTOS 2013 Annual Meeting, October 30-November 2, 2013, New York, 2013. e-Pub 2013.
- Kivlin, CM, Ma XY, Zhu QS, Belousov R, Ingram D, Al Sannaa GA, May C, Garnett J, Bolshakov S, McCutcheon I, Slopis JM, Pollock RE, Lev D, Lazar AJ, Torres KE. Downregulation of ERCC6 is a Potential Mechanism for the Effect of Parp Inhibition in Malignant Peripheral Nerve Sheath Tumor (MPNST). Presented at the CTOS 2013 Annual Meeting, October 30-November 2, 2013 New York, 2013. e-Pub 2013.
- Sadighi ZS, Pearlman ML, Slopis JM, Vats TS, Khatua S. Diffuse leptomeningeal relapse following gross total resection in a spinal cord pilocytic astrocytoma with oligodendroglial features and 1p19q deletion. Neuro-Oncology 13(Suppl 3):iii42, 2011. e-Pub 2011.
- Sadighi Z, Vats T, Khatua S, Ater J, Slopis J, Dhamne C, Schiffman J. Looking through the patient's eyes. Proceedings of 43rd Congress of the International Society for Paediatric Oncology 2011 Auckland, New Zealand, 2011. e-Pub 2011.
- Subbiah V, Slopis JM, Hong DS, Angelo LS, McCutcheon IE, Kurzrock R. Treatment of patients with advanced neurofibromatosis type 2 (NF2) with novel molecularly targeted therapies. J Clin Oncol 29(Suppl), 2011. e-Pub 2011.
- Slopis JM. Early Childhood Development in Neurofibromatosis Type I. Presented in Platform Session at Children's Tumor Foundation Neurofibromatosis Research Meeting in Aspen, CO, 2006. e-Pub 2006.
- Slopis JM. Spinal Malformations in Neurofibromatosis Type I. Presented at the Tumor Foundation Neurofibromatosis Research Meeting in Aspen, CO, 2006. e-Pub 2006.
- Winter D, A, Moore BD, Slopis JM, Jackson EF. Relationship of corpus callosum morphology to symptoms of attention deficit hyperactivity disorder in children diagnosed with neurofibromatosis, type 1. Journal of the International Neuropsychological Society 5:2, 1999. e-Pub 1999.
- Slopis JM. Neuroanatomical predictors of neurospsychological functioning in children with neurofibromatosis. J. Clin Exp Neuropsychol 4:223, 1998. e-Pub 1998.
- Narayana PA, Slopis JM, Jackson EF, Fotedar LK, Butler IJ. In vivo muscle magnetic resonance spectroscopy in a family with mitochondrial cytopathy: A defect in fat metabolism. 7th Annual Meeting of the Society of Magnetic Resonance in Medicine Book of Abstracts:300, 1988. e-Pub 1988.
- Duman R, Slopis JM, Kendall DA, Enna SJ. Facilitation of the neurochemical response to antidepressants by ACTH and Yohimbine. Proceedings of the Society of Neuroscience 7:104, 1981. e-Pub 1981.
- Debnam JM, Ketonen L, Slopis JM, McCutcheon IE, Hamberg LM, Hunter GJ. Multidetector CT Evaluation of the Spine in Patients with Neurofibromatosis Type I. Presented at the American Society of Neuroradiology 45th Annual Meeting.
Book Chapters
- Schiffman J, Slopis JM. Neurofibromatosis: Tumors of the Optic Pathway. In: Oncologic Ophthalmology. Series 6. Cambridge University Press, 419-431, 2011.
- Moore, BD, Slopis, JM. Neurofibromatosis, 211-227, 2008.
- Moore BD, Slopis JM. Neurofibromatosis. In: Cognition and Cancer. Cambridge University Press, 211-227, 2008.
- Moore BD, Slopis JM. Neurofibromatosis. In: Neurogenetic Developmental Disorders: Variation of Manifestation in Childhood. The MIT Press, 133-161, 2007.
- Kendall DA, Slopis J, Duman R, Stancel GM, Enna SJ. The influence of hormones on drug-induced modifications in neurotransmitter receptor binding. In: Prog Clin Biol Res. AR Liss, Inc, 193-207, 1982.
- Duman R, Slopis JM Kendall DA, Enna SJ. Facilitation of the neurochemical response to antidepressants by Yohimbine. In: Serotonin in Biological Psychiatry. Raven Press, 325, 1982.
Letters to the Editor
- Ertaş, M, Ertekin, C, Efendi, H, Uysal, H, Eisen, AA, Kern, RZ, Chroni, E, Panayiotopoulos, CP, Iñtiguez, C, Escobar, H, Jimenez‐Escrig, A, McKinley, KL, Harati, Y, Campos, Y, Esteban, J, Cabello, A, Arenas, J, Chu, NS, Huang, CC, Wei, YH, Ozaki, I, Baba, M, Ogawa, M, Matsunaga, M, Simpson, DM, Tagliati, M, Tanaka, M, Bruyland, M, Lissens, W, De Waele, M, Demanet, C, Palmisani, MT, Evoli, A, Batocchi, AP, Bartoccioni, E, Tonali, P, Fredericks, EJ, Bello, LE, Hagenfeldt, L, von Döubeln, U, Solders, G, Kaijser, L, Jabre, JF, Mancias, P, Slopis, JM, Yeakley, JW, Vriesendorp, FJ. Letters to the editor. Muscle & Nerve 17: 1225-1238, 1994.
- Bohan, TP, Dominguez, R, Slopis, JM, Vila Coro, AA. In Reply. American Journal of Diseases of Children 146: 278-279, 1992.
Patient Reviews
CV information above last modified March 06, 2026